The SOCS box-Adapting proteins for ubiquitination and proteasomal degradation

IUBMB Life

Volumn 64, Issue 4, 2012, Pages 316-323

  Linossi, Edmond M ^a,b   Nicholson, Sandra E ^a,b  

^a WALTER AND ELIZA HALL INSTITUTE OF MEDICAL RESEARCH   (Australia)

^b UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

cullin; E3 ligase; proteasome; SOCS box; ubiquitin

Indexed keywords

ANKYRIN; CULLIN; CULLIN 5; ELONGIN B; ELONGIN C; GUANOSINE TRIPHOSPHATASE; LEUCINE; PROTEASOME; SUPPRESSOR OF CYTOKINE SIGNALING; UBIQUITIN PROTEIN LIGASE; UNCLASSIFIED DRUG;

HUMAN; NONHUMAN; PROTEIN DEGRADATION; PROTEIN DOMAIN; PROTEIN FUNCTION; PROTEIN INTERACTION; PROTEIN MOTIF; REVIEW; SIGNAL TRANSDUCTION; UBIQUITINATION;

AMINO ACID SEQUENCE; ANKYRIN REPEAT; HUMANS; MODELS, MOLECULAR; MOLECULAR SEQUENCE DATA; PROTEASOME ENDOPEPTIDASE COMPLEX; PROTEIN INTERACTION DOMAINS AND MOTIFS; SEQUENCE HOMOLOGY, AMINO ACID; SRC HOMOLOGY DOMAINS; SUPPRESSOR OF CYTOKINE SIGNALING PROTEINS; UBIQUITINATION;

EID: 84859062753     PISSN: 15216543     EISSN: 15216551     Source Type: Journal    
DOI: 10.1002/iub.1011     Document Type: Review

References (83)

1. Komander, D., (2009) The emerging complexity of protein ubiquitination. Biochem. Soc. Trans. 37, 937-953.
2. Hatakeyama, S., (2011) TRIM proteins and cancer. Nat. Rev. Cancer 11, 792-804.
3. Hoyne, G. F., (2011) Mechanisms that regulate peripheral immune responses to control organ-specific autoimmunity. Clin. Dev. Immunol. 2011, 294968.
4. Vucic, D., Dixit, V. M., and, Wertz, I. E., (2011) Ubiquitylation in apoptosis: a post-translational modification at the edge of life and death. Nat. Rev. Mol. Cell Biol. 12, 439-452.
5. Harhaj, E. W., and, Dixit, V. M., (2011) Deubiquitinases in the regulation of NF-ÎB signaling. Cell Res. 21, 22-39.
6. Deshaies, R. J., and, Joazeiro, C. A., (2009) RING domain E3 ubiquitin ligases. Annu. Rev. Biochem. 78, 399-434.
7. Kamura, T., Maenaka, K., Kotoshiba, S., Matsumoto, M., Kohda, D., et al. (2004) VHL-box and SOCS-box domains determine binding specificity for Cul2-Rbx1 and Cul5-Rbx2 modules of ubiquitin ligases. Genes Dev. 18, 3055-3065. (Pubitemid 39658174)
8. Hilton, D. J., Richardson, R. T., Alexander, W. S., Viney, E. M., Willson, T. A., et al. (1998) Twenty proteins containing a C-terminal SOCS box form five structural classes. Proc. Natl. Acad. Sci. USA 95, 114-119. (Pubitemid 28103916)
9. Croker, B. A., Kiu, H., and, Nicholson, S. E., (2008) SOCS regulation of the JAK/STAT signalling pathway. Semin. Cell Dev. Biol. 19, 414-422.
10. Yoshimura, A., Naka, T., and, Kubo, M., (2007) SOCS proteins, cytokine signalling and immune regulation. Nat. Rev. Immunol. 7, 454-465. (Pubitemid 46834848)
11. Starr, R., Willson, T. A., Viney, E. M., Murray, L. J., Rayner, J. R., et al. (1997) A family of cytokine-inducible inhibitors of signalling. Nature 387, 917-921. (Pubitemid 27289594)
12. Kibel, A., Iliopoulos, O., DeCaprio, J. A., and, Kaelin, W. G., Jr., (1995) Binding of the von Hippel-Lindau tumor suppressor protein to elongin B and C. Science 269, 1444-1446.
13. Iwai, K., Yamanaka, K., Kamura, T., Minato, N., Conaway, R. C., et al. (1999) Identification of the von Hippel-lindau tumor-suppressor protein as part of an active E3 ubiquitin ligase complex. Proc. Natl. Acad. Sci. USA 96, 12436-12441. (Pubitemid 29513520)
14. Kamura, T., Sato, S., Haque, D., Liu, L., Kaelin, W. G., Jr., et al. (1998) The elongin BC complex interacts with the conserved SOCS-box motif present in members of the SOCS, ras, WD-40 repeat, and ankyrin repeat families. Genes Dev. 12, 3872-3881. (Pubitemid 29024849)
15. Zhang, J. G., Farley, A., Nicholson, S. E., Willson, T. A., Zugaro, L. M., et al. (1999) The conserved SOCS box motif in suppressors of cytokine signaling binds to elongins B and C and may couple bound proteins to proteasomal degradation. Proc. Natl. Acad. Sci. USA 96, 2071-2076. (Pubitemid 29117869)
16. Babon, J. J., Sabo, J. K., Soetopo, A., Yao, S., Bailey, M. F., et al. (2008) The SOCS box domain of SOCS3: structure and interaction with the elonginBC-cullin5 ubiquitin ligase. J. Mol. Biol. 381, 928-940.
17. Stebbins, C. E., Kaelin, W. G., Jr., and, Pavletich, N. P., (1999) Structure of the VHL-elonginC-elonginB complex: implications for VHL tumor suppressor function. Science 284, 455-461. (Pubitemid 29289612)
18. Bullock, A. N., Debreczeni, J. E., Edwards, A. M., Sundstrom, M., and, Knapp, S., (2006) Crystal structure of the SOCS2-elongin C-elongin B complex defines a prototypical SOCS box ubiquitin ligase. Proc. Natl. Acad. Sci. USA 103, 7637-7642.
19. Kile, B. T., Schulman, B. A., Alexander, W. S., Nicola, N. A., Martin, H. M., et al. (2002) The SOCS box: a tale of destruction and degradation. Trends Biochem. Sci. 27, 235-241. (Pubitemid 34655444)
20. Bullock, A. N., Rodriguez, M. C., Debreczeni, J. E., Songyang, Z., and, Knapp, S., (2007) Structure of the SOCS4-elonginB/C complex reveals a distinct SOCS box interface and the molecular basis for SOCS-dependent EGFR degradation. Structure 15, 1493-1504. (Pubitemid 350051927)
21. Haan, S., Ferguson, P., Sommer, U., Hiremath, M., McVicar, D. W., et al. (2003) Tyrosine phosphorylation disrupts elongin interaction and accelerates SOCS3 degradation. J. Biol. Chem. 278, 31972-31979. (Pubitemid 37048385)
22. Zimmerman, E. S., Schulman, B. A., and, Zheng, N., (2010) Structural assembly of cullin-RING ubiquitin ligase complexes. Curr. Opin. Struct. Biol. 20, 714-721.
23. Zheng, N., Schulman, B. A., Song, L., Miller, J. J., Jeffrey, P. D., et al. (2002) Structure of the Cul1-Rbx1-Skp1-F boxSkp2 SCF ubiquitin ligase complex. Nature 416, 703-709. (Pubitemid 34429140)
24. Schulman, B. A., Carrano, A. C., Jeffrey, P. D., Bowen, Z., Kinnucan, E. R., et al. (2000) Insights into SCF ubiquitin ligases from the structure of the Skp1-Skp2 complex. Nature 408, 381-386.
25. Babon, J. J., McManus, E., Yao, S., DeSouza, D. P., Willson, T. A., et al. (2006) Structure of mouse SOCS3 reveals the structural basis of the extended SH2 domain function and identifies an unstructured insertion that regulates in vivo stability. Mol. Cell 22, 205-216. (Pubitemid 44316440)
26. Sasaki, A., Yasukawa, H., Suzuki, A., Kamizono, S., Syoda, T., et al. (1999) Cytokine-inducible SH2 protein-3 (CIS3/SOCS3) inhibits janus tyrosine kinase by binding through the N-terminal kinase inhibitory region as well as SH2 domain. Genes Cells 4, 339-351. (Pubitemid 29359449)
27. Alexander, W. S., Starr, R., Metcalf, D., Nicholson, S. E., Farley, A., et al. (1999) Suppressors of cytokine signaling (SOCS): negative regulators of signal transduction. J. Leukoc. Biol. 66, 588-592. (Pubitemid 29489885)
28. Croker, B. A., Metcalf, D., Robb, L., Wei, W., Mifsud, S., et al. (2004) SOCS3 is a critical physiological negative regulator of G-CSF signaling and emergency granulopoiesis. Immunity 20, 153-165. (Pubitemid 38258392)
29. Croker, B. A., Krebs, D. L., Zhang, J. G., Wormald, S., Willson, T. A., et al. (2003) SOCS3 negatively regulates IL-6 signaling in vivo. Nat. Immunol. 4, 540-545. (Pubitemid 36701336)
30. Starr, R., Metcalf, D., Elefanty, A. G., Brysha, M., Willson, T. A., et al. (1998) Liver degeneration and lymphoid deficiencies in mice lacking suppressor of cytokine signaling-1. Proc. Natl. Acad. Sci. USA 95, 14395-14399. (Pubitemid 28549378)
31. Boyle, K., Egan, P., Rakar, S., Willson, T. A., Wicks, I. P., et al. (2007) The SOCS box of suppressor of cytokine signaling-3 contributes to the control of G-CSF responsiveness in vivo. Blood 110, 1466-1474. (Pubitemid 47443961)
32. Zhang, J. G., Metcalf, D., Rakar, S., Asimakis, M., Greenhalgh, C. J., et al. (2001) The SOCS box of suppressor of cytokine signaling-1 is important for inhibition of cytokine action in vivo. Proc. Natl. Acad. Sci. USA 98, 13261-13265. (Pubitemid 33051350)
33. Babon, J. J., Sabo, J. K., Zhang, J. G., Nicola, N. A., and, Norton, R. S., (2009) The SOCS box encodes a hierarchy of affinities for Cullin5: implications for ubiquitin ligase formation and cytokine signalling suppression. J. Mol. Biol. 387, 162-174.
34. Greenhalgh, C. J., Rico-Bautista, E., Lorentzon, M., Thaus, A. L., Morgan, P. O., et al. (2005) SOCS2 negatively regulates growth hormone action in vitro and in vivo. J. Clin. Invest. 115, 397-406. (Pubitemid 40385481)
35. De Sepulveda, P., Ilangumaran, S., and, Rottapel, R., (2000) Suppressor of cytokine signaling-1 inhibits VAV function through protein degradation. J. Biol. Chem. 275, 14005-14008. (Pubitemid 30339671)
36. Ungureanu, D., Saharinen, P., Junttila, I., Hilton, D. J., and, Silvennoinen, O., (2002) Regulation of Jak2 through the ubiquitin-proteasome pathway involves phosphorylation of Jak2 on Y1007 and interaction with SOCS-1. Mol. Cell. Biol. 22, 3316-3326. (Pubitemid 34453973)
37. Kamizono, S., Hanada, T., Yasukawa, H., Minoguchi, S., Kato, R., et al. (2001) The SOCS box of SOCS-1 accelerates ubiquitin-dependent proteolysis of TEL-JAK2. J. Biol. Chem. 276, 12530-12538.
38. Frantsve, J., Schwaller, J., Sternberg, D. W., Kutok, J., and, Gilliland, D. G., (2001) Socs-1 inhibits TEL-JAK2-mediated transformation of hematopoietic cells through inhibition of JAK2 kinase activity and induction of proteasome-mediated degradation. Mol. Cell. Biol. 21, 3547-3557. (Pubitemid 32381790)
39. Rui, L., Yuan, M., Frantz, D., Shoelson, S., and, White, M. F., (2002) SOCS-1 and SOCS-3 block insulin signaling by ubiquitin-mediated degradation of IRS1 and IRS2. J. Biol. Chem. 277, 42394-42398. (Pubitemid 35257562)
40. Piganis, R. A., De Weerd, N. A., Gould, J. A., Schindler, C. W., Mansell, A., et al. (2011) Suppressor of cytokine signaling (SOCS) 1 inhibits type I interferon (IFN) signaling via the interferon α receptor (IFNAR1)-associated tyrosine kinase Tyk2. J. Biol. Chem. 286, 33811-33818.
41. Metcalf, D., Greenhalgh, C. J., Viney, E., Willson, T. A., Starr, R., et al. (2000) Gigantism in mice lacking suppressor of cytokine signalling-2. Nature 405, 1069-1073. (Pubitemid 30447793)
42. Vesterlund, M., Zadjali, F., Persson, T., Nielsen, M. L., Kessler, B. M., et al. (2011) The SOCS2 ubiquitin ligase complex regulates growth hormone receptor levels. PLoS One 6, e25358.
43. Lee, S. H., Yun, S., Piao, Z. H., Jeong, M., Kim, D. O., et al. (2010) Suppressor of cytokine signaling 2 regulates IL-15-primed human NK cell function via control of phosphorylated Pyk2. J. Immunol. 185, 917-928.
44. Nicholson, S. E., De Souza, D., Fabri, L. J., Corbin, J., Willson, T. A., et al. (2000) Suppressor of cytokine signaling-3 preferentially binds to the SHP-2-binding site on the shared cytokine receptor subunit gp130. Proc. Natl. Acad. Sci. USA 97, 6493-6498. (Pubitemid 30412741)
45. Tanaka, Y., Tanaka, N., Saeki, Y., Tanaka, K., Murakami, M., et al. (2008) c-Cbl-dependent monoubiquitination and lysosomal degradation of gp130. Mol. Cell. Biol. 28, 4805-4818.
46. Boyle, K., Zhang, J. G., Nicholson, S. E., Trounson, E., Babon, J. J., et al. (2009) Deletion of the SOCS box of suppressor of cytokine signaling 3 (SOCS3) in embryonic stem cells reveals SOCS box-dependent regulation of JAK but not STAT phosphorylation. Cell Signal. 21, 394-404.
47. Irandoust, M. I., Aarts, L. H., Roovers, O., Gits, J., Erkeland, S. J., et al. (2007) Suppressor of cytokine signaling 3 controls lysosomal routing of G-CSF receptor. EMBO J. 26, 1782-1793. (Pubitemid 46624051)
48. Wolfler, A., Irandoust, M., Meenhuis, A., Gits, J., Roovers, O., et al. (2009) Site-specific ubiquitination determines lysosomal sorting and signal attenuation of the granulocyte colony-stimulating factor receptor. Traffic 10, 1168-1179.
49. Krebs, D. L., Uren, R. T., Metcalf, D., Rakar, S., Zhang, J. G., et al. (2002) SOCS-6 binds to insulin receptor substrate 4, and mice lacking the SOCS-6 gene exhibit mild growth retardation. Mol. Cell. Biol. 22, 4567-4578. (Pubitemid 34620394)
50. Banks, A. S., Li, J., McKeag, L., Hribal, M. L., Kashiwada, M., et al. (2005) Deletion of SOCS7 leads to enhanced insulin action and enlarged islets of Langerhans. J. Clin. Invest. 115, 2462-2471. (Pubitemid 41266208)
51. Bayle, J., Letard, S., Frank, R., Dubreuil, P., and, De Sepulveda, P., (2004) Suppressor of cytokine signaling 6 associates with KIT and regulates KIT receptor signaling. J. Biol. Chem. 279, 12249-12259. (Pubitemid 38445790)
52. Zadjali, F., Pike, A. C., Vesterlund, M., Sun, J., Wu, C., et al. (2011) Structural basis for c-KIT inhibition by the suppressor of cytokine signaling 6 (SOCS6) ubiquitin ligase. J. Biol. Chem. 286, 480-490.
53. Choi, Y. B., Son, M., Park, M., Shin, J., and, Yun, Y., (2010) SOCS-6 negatively regulates T cell activation through targeting p56lck to proteasomal degradation. J. Biol. Chem. 285, 7271-7280.
54. Kohroki, J., Nishiyama, T., Nakamura, T., and, Masuho, Y., (2005) ASB proteins interact with Cullin5 and Rbx2 to form E3 ubiquitin ligase complexes. FEBS Lett. 579, 6796-6802. (Pubitemid 41773689)
55. Heuze, M. L., Guibal, F. C., Banks, C. A., Conaway, J. W., Conaway, R. C., et al. (2005) ASB2 is an elongin BC-interacting protein that can assemble with Cullin 5 and Rbx1 to reconstitute an E3 ubiquitin ligase complex. J. Biol. Chem. 280, 5468-5474. (Pubitemid 40280022)
56. Marcotte, E. M., Pellegrini, M., Yeates, T. O., and, Eisenberg, D., (1999) A census of protein repeats. J. Mol. Biol. 293, 151-160. (Pubitemid 29494877)
57. Sedgwick, S. G., and, Smerdon, S. J., (1999) The ankyrin repeat: a diversity of interactions on a common structural framework. Trends Biochem. Sci. 24, 311-316. (Pubitemid 29366805)
58. Michaely, P., and, Bennett, V., (1992) The ANK repeat: a ubiquitous motif involved in macromolecular recognition. Trends Cell. Biol. 2, 127-129.
59. Bello, N. F., Lamsoul, I., Heuze, M. L., Metais, A., Moreaux, G., et al. (2009) The E3 ubiquitin ligase specificity subunit ASB2β is a novel regulator of muscle differentiation that targets filamin B to proteasomal degradation. Cell Death Differ. 16, 921-932.
60. Heuze, M. L., Lamsoul, I., Baldassarre, M., Lad, Y., Leveque, S., et al. (2008) ASB2 targets filamins A and B to proteasomal degradation. Blood 112, 5130-5140.
61. Razinia, Z., Baldassarre, M., Bouaouina, M., Lamsoul, I., Lutz, P. G., et al. (2011) The E3 ubiquitin ligase specificity subunit ASB2α targets filamins for proteasomal degradation by interacting with the filamin actin-binding domain. J. Cell Sci. 124, 2631-2641.
62. Chung, A. S., Guan, Y. J., Yuan, Z. L., Albina, J. E., and, Chin, Y. E., (2005) Ankyrin repeat and SOCS box 3 (ASB3) mediates ubiquitination and degradation of tumor necrosis factor receptor II. Mol. Cell. Biol. 25, 4716-4726. (Pubitemid 40705774)
63. Li, J. Y., Chai, B. X., Zhang, W., Wang, H., and, Mulholland, M. W., (2010) Expression of ankyrin repeat and suppressor of cytokine signaling box protein 4 (Asb-4) in proopiomelanocortin neurons of the arcuate nucleus of mice produces a hyperphagic, lean phenotype. Endocrinology 151, 134-142.
64. Li, J. Y., Chai, B., Zhang, W., Wu, X., Zhang, C., et al. (2011) Ankyrin repeat and SOCS box containing protein 4 (Asb-4) colocalizes with insulin receptor substrate 4 (IRS4) in the hypothalamic neurons and mediates IRS4 degradation. BMC Neurosci. 12, 95.
65. Debrincat, M. A., Zhang, J. G., Willson, T. A., Silke, J., Connolly, L. M., et al. (2007) Ankyrin repeat and suppressors of cytokine signaling box protein asb-9 targets creatine kinase B for degradation. J. Biol. Chem. 282, 4728-4737. (Pubitemid 47100962)
66. Kwon, S., Kim, D., Rhee, J. W., Park, J. A., Kim, D. W., et al. (2010) ASB9 interacts with ubiquitous mitochondrial creatine kinase and inhibits mitochondrial function. BMC Biol. 8, 23.
67. Diks, S. H., Sartori da Silva, M. A., Hillebrands, J. L., Bink, R. J., Versteeg, H. H., et al. (2008) d-Asb11 is an essential mediator of canonical Delta-Notch signalling. Nat. Cell Biol. 10, 1190-1198.
68. Diks, S. H., Bink, R. J., van de Water, S., Joore, J., van Rooijen, C., et al. (2006) The novel gene asb11: a regulator of the size of the neural progenitor compartment. J. Cell Biol. 174, 581-592. (Pubitemid 44231869)
69. Sartori da Silva, M. A., Tee, J. M., Paridaen, J., Brouwers, A., Runtuwene, V., et al. (2010) Essential role for the d-Asb11 cul5 Box domain for proper notch signaling and neural cell fate decisions in vivo. PLoS One 5, e14023.
70. Lewis, R. S., Kolesnik, T. B., Kuang, Z., D'Cruz, A. A., Blewitt, M. E., et al. (2011) TLR regulation of SPSB1 controls inducible nitric oxide synthase induction. J. Immunol. 187, 3798-3805.
71. Kuang, Z., Lewis, R. S., Curtis, J. M., Zhan, Y., Saunders, B. M., et al. (2010) The SPRY domain-containing SOCS box protein SPSB2 targets iNOS for proteasomal degradation. J. Cell Biol. 190, 129-141.
72. Nishiya, T., Matsumoto, K., Maekawa, S., Kajita, E., Horinouchi, T., et al. (2011) Regulation of inducible nitric-oxide synthase by the SPRY domain- and SOCS box-containing proteins. J. Biol. Chem. 286, 9009-9019.
73. Kugler, J. M., Woo, J. S., Oh, B. H., and, Lasko, P., (2010) Regulation of Drosophila vasa in vivo through paralogous cullin-RING E3 ligase specificity receptors. Mol. Cell. Biol. 30, 1769-1782.
74. Choi, D. W., Seo, Y. M., Kim, E. A., Sung, K. S., Ahn, J. W., et al. (2008) Ubiquitination and degradation of homeodomain-interacting protein kinase 2 by WD40 repeat/SOCS box protein WSB-1. J. Biol. Chem. 283, 4682-4689.
75. Dentice, M., Bandyopadhyay, A., Gereben, B., Callebaut, I., Christoffolete, M. A., et al. (2005) The Hedgehog-inducible ubiquitin ligase subunit WSB-1 modulates thyroid hormone activation and PTHrP secretion in the developing growth plate. Nat. Cell Biol. 7, 698-705. (Pubitemid 40975751)
76. Erkeland, S. J., Aarts, L. H., Irandoust, M., Roovers, O., Klomp, A., et al. (2007) Novel role of WD40 and SOCS box protein-2 in steady-state distribution of granulocyte colony-stimulating factor receptor and G-CSF-controlled proliferation and differentiation signaling. Oncogene 26, 1985-1994. (Pubitemid 46514741)
77. Monni, R., Santos, S. C., Mauchauffe, M., Berger, R., Ghysdael, J., et al. (2001) The TEL-Jak2 oncoprotein induces Socs1 expression and altered cytokine response in Ba/F3 cells. Oncogene 20, 849-858. (Pubitemid 32198178)
78. Ryo, A., Suizu, F., Yoshida, Y., Perrem, K., Liou, Y. C., et al. (2003) Regulation of NF-ÎB signaling by Pin1-dependent prolyl isomerization and ubiquitin-mediated proteolysis of p65/RelA. Mol. Cell 12, 1413-1426. (Pubitemid 38037011)
79. Kawaguchi, T., Yoshida, T., Harada, M., Hisamoto, T., Nagao, Y., et al. (2004) Hepatitis C virus down-regulates insulin receptor substrates 1 and 2 through up-regulation of suppressor of cytokine signaling 3. Am. J. Pathol. 165, 1499-1508. (Pubitemid 39435150)
80. Nordstrom-O'Brien, M., van der Luijt, R. B., van Rooijen, E., van den Ouweland, A. M., Majoor-Krakauer, D. F., et al. (2010) Genetic analysis of von Hippel-Lindau disease. Hum. Mutat. 31, 521-537.
81. Wang, J., Muntean, A. G., Hess, J. L., (2012) ECSASB2 mediates MLL degradation during hematopoietic differentiation. Blood 119, 1151-1161.
82. Nie, L., Zhao, Y., Wu, W., Yang, Y. Z., Wang, H. C., et al. (2011) Notch-induced Asb2 expression promotes protein ubiquitination by forming non-canonical E3 ligase complexes. Cell Res. 21, 754-769.
83. Wu, W., Sun, X. H., (2011) A mechanism underlying NOTCH-induced and ubiquitin-mediated JAK3 degradation. J. Biol. Chem. 286, 41153-41162.